1.1 Market Snapshot and Key Findings
1.2 Europe Market Size and Forecast (2025–2035)
1.3 Market Volume Analysis (Tons/Billion Units)
1.4 Average Selling Price (ASP) Trends
1.5 Demand–Supply Overview
1.6 Key Market Drivers and Challenges
1.7 Regulatory and Compliance Highlights
1.8 Sustainability and Circular Packaging Trends
1.9 Strategic Insights and Analyst Recommendations
1.10 Future Outlook and Opportunity Assessment
2.1 Research Objectives
2.2 Market Definition and Scope
2.3 Market Assumptions and Limitations
2.4 Research Methodology Framework
2.5 Data Collection and Validation Approach
2.6 Forecasting Methodology
2.7 Currency Conversion and Pricing Standards
2.8 Key Industry Indicators Considered
2.9 Economic and Pharmaceutical Industry Impact Assessment
3.1 Overview of Pharmaceutical Packaging Materials Industry
3.2 Role of Packaging Materials in Pharmaceutical Safety and Compliance
3.3 Market Evolution and Industry Transformation
3.4 Packaging Material Ecosystem Overview
3.5 Value Chain Analysis
3.6 Key Stakeholders in the Market
3.7 Packaging Material Selection Criteria in Pharmaceuticals
3.8 Primary, Secondary, and Tertiary Packaging Overview
3.9 Demand Trends Across Drug Categories
3.10 Strategic Insights: Transition Toward High-Barrier and Sustainable Packaging Materials
4.1 Revenue Analysis (2025–2035)
4.2 Volume Analysis (2025–2035)
4.3 Historical Market Analysis (2020–2024)
4.4 Year-on-Year Growth Trends
4.5 Incremental Dollar Opportunity Analysis
4.6 Market Attractiveness Analysis
4.7 Demand Penetration Analysis
4.8 Revenue vs Volume Growth Comparison
4.9 Country-Level Contribution Analysis
4.10 Strategic Insights: High-Growth Packaging Material Segments
5.1 Average Selling Price Analysis by Material Type
5.2 Average Selling Price Analysis by Application
5.3 Country-Level Pricing Benchmarking
5.4 Resin Price Trend Analysis
5.5 Glass Material Cost Trends
5.6 Aluminium Foil and Closure Material Pricing Trends
5.7 Manufacturing Cost Structure Analysis
5.8 Margin Analysis Across the Value Chain
5.9 Packaging Cost Contribution in Pharmaceutical Products
5.10 Strategic Insights: Cost Optimization and Margin Enhancement Strategies
6.1 Pharmaceutical Packaging Materials Supply Chain Overview
6.2 Raw Material Suppliers
6.3 Resin and Polymer Manufacturers
6.4 Glass Packaging Manufacturers
6.5 Packaging Converters and Component Suppliers
6.6 Pharmaceutical Packaging Integrators
6.7 Pharmaceutical Manufacturers and CMOs
6.8 Distribution and Logistics Network
6.9 Supply Chain Risks and Bottlenecks
6.10 Strategic Insights: Regionalization and Supply Security Trends
7.1 Market Drivers
7.1.1 Rising Pharmaceutical Production in Europe
7.1.2 Growth in Biologics and Injectable Drugs
7.1.3 Increasing Demand for Tamper-Evident Packaging
7.1.4 Expansion of Generic Drug Manufacturing
7.1.5 Growing Demand for Child-Resistant and Senior-Friendly Packaging
7.2 Market Restraints
7.2.1 Stringent Regulatory Compliance Costs
7.2.2 Volatility in Polymer and Glass Prices
7.2.3 Sustainability Challenges in Plastic Packaging
7.3 Market Opportunities
7.3.1 Recyclable and Sustainable Packaging Materials
7.3.2 High-Barrier Flexible Packaging Innovations
7.3.3 Smart and Connected Pharmaceutical Packaging
7.3.4 Growth in Prefilled Syringe Packaging Demand
7.4 Market Challenges
7.4.1 Sterility and Contamination Risks
7.4.2 Supply Chain Disruptions in Medical Packaging
7.4.3 Recycling Limitations for Multi-Layer Packaging Materials
7.5 Strategic Insights: Shift Toward Advanced Drug Delivery Packaging Solutions
8.1 European Pharmaceutical Packaging Regulations
8.2 EU GMP Packaging Compliance Standards
8.3 Serialization and Track-and-Trace Regulations
8.4 Child-Resistant and Tamper-Evident Packaging Standards
8.5 EU Packaging and Packaging Waste Regulation (PPWR)
8.6 Sustainability and Recyclability Targets
8.7 ISO and Pharmacopoeia Standards
8.8 Regulations for Contact-Sensitive Pharmaceutical Materials
8.9 Strategic Insights: Regulatory Impact on Material Innovation
9.1 High-Barrier Packaging Material Innovations
9.2 Advanced Polymer Developments
9.3 Cyclic Olefin Polymer (COP) and Cyclic Olefin Copolymer (COC) Trends
9.4 Smart Labels and Connected Packaging Technologies
9.5 Digital Printing and Serialization Technologies
9.6 Lightweight and Sustainable Packaging Innovations
9.7 Automation in Pharmaceutical Packaging Manufacturing
9.8 Anti-Counterfeit Packaging Technologies
9.9 Patent and Innovation Landscape Analysis
9.10 Strategic Insights: Future Technology Roadmap
10.1 Overview
10.2 High-Density Polyethylene (HDPE)
10.3 Low-Density Polyethylene (LDPE)
10.4 Polyester (PE)
10.5 Polypropylene (PP)
10.6 Polyvinyl Chloride (PVC)
10.7 Polyethylene Terephthalate (PET)
10.8 Revenue and Volume Forecast by Material
10.9 Material Performance Benchmarking
10.10 Strategic Insights by Material Type
11.1 Overview
11.2 Plastic Bottles
11.3 Blister Packs
11.4 Labels & Accessories
11.5 Caps & Closures
11.6 Medical Specialty Bags
11.7 Pre-Filled Syringes
11.8 Ampoules
11.9 Jars & Canisters
11.10 Other Applications
11.11 Revenue and Volume Forecast by Application
11.12 Strategic Insights by Application
12.1 Germany
12.1.1 Market Size and Forecast
12.1.2 Pharmaceutical Manufacturing Overview
12.1.3 Packaging Material Demand Analysis
12.1.4 Competitive Landscape
12.1.5 Regulatory Environment
12.2 United Kingdom
12.2.1 Market Size and Forecast
12.2.2 Biopharmaceutical Packaging Trends
12.2.3 Brexit Impact on Packaging Supply Chains
12.2.4 Demand Analysis by Drug Type
12.3 France
12.3.1 Market Size and Forecast
12.3.2 Glass and Flexible Packaging Demand Trends
12.3.3 Regulatory and Sustainability Trends
12.4 Italy
12.4.1 Market Size and Forecast
12.4.2 Pharmaceutical Export Packaging Analysis
12.4.3 Manufacturing and Innovation Landscape
12.5 Russia
12.5.1 Market Size and Forecast
12.5.2 Domestic Pharmaceutical Production Trends
12.5.3 Packaging Localization Analysis
12.6 Comparative Country Analysis
12.7 Country-Wise Pricing Benchmarking
12.8 Trade and Import Dependency Analysis
12.9 Strategic Insights by Country
13.1 Europe Pharmaceutical Packaging Materials Trade Overview
13.2 Import Analysis by Material Type
13.3 Export Analysis by Packaging Application
13.4 Key Exporting Countries
13.5 Key Importing Countries
13.6 Trade Flow Mapping
13.7 Customs Duties and Tariff Analysis
13.8 Raw Material Dependency Analysis
13.9 Strategic Insights: Localization and Nearshoring Trends
14.1 Market Share Analysis
14.2 Competitive Benchmarking
14.3 Product Portfolio Analysis
14.4 Packaging Material Innovation Benchmarking
14.5 Manufacturing Footprint Analysis
14.6 Strategic Partnerships and Collaborations
14.7 Mergers and Acquisitions
14.8 New Product Launches and Expansions
14.9 ESG and Sustainability Strategy Comparison
14.10 Strategic Insights: Competitive Intensity Assessment
15.1 Amcor Plc
15.2 Constantia Flexibles
15.3 Schott AG
15.4 Bormioli Pharma S.p.A
15.5 SGD Pharma SAS
15.6 Perlen Packaging AG
15.7 Stevanato Group S.p.A
15.8 Aptar Group Inc.
15.9 Gerresheimer AG
15.10 Gaplast GmbH
15.11 Renolit
(Each company profile will include:)
• Company Overview
• Business Segments
• Pharmaceutical Packaging Material Portfolio
• Production Capacity
• Geographic Presence
• Financial Performance
• Recent Developments
• Strategic Initiatives
• R&D and Innovation Focus
• SWOT Analysis
16.1 Porter’s Five Forces Analysis
16.2 PESTLE Analysis
16.3 Market Attractiveness Matrix
16.4 Competitive Positioning Matrix
16.5 Opportunity Mapping and White Space Analysis
16.6 Risk Assessment Framework
16.7 Supply Chain Risk and Dependency Analysis
16.8 Strategic Insights: Investment Prioritization Areas
17.1 Pharmaceutical Packaging Investment Trends
17.2 Capacity Expansion Analysis
17.3 Sustainability Investment Trends
17.4 M&A and Strategic Partnership Analysis
17.5 Venture Capital and Innovation Funding
17.6 Smart Packaging Investment Trends
17.7 High-Growth Packaging Material Opportunities
17.8 Strategic Insights: Emerging Investment Hotspots
18.1 Europe Market Forecast to 2035
18.2 Future Material Innovation Trends
18.3 Evolution of Sustainable Pharmaceutical Packaging
18.4 Smart Packaging and Digital Traceability Outlook
18.5 Future Demand by Drug Delivery Type
18.6 Scenario Analysis (Optimistic, Base, Conservative)
18.7 Analyst Recommendations
18.8 Strategic Conclusions and Key Takeaways
Principal Research Analyst
Vidyesh Swar is a Senior Research Analyst at Towards Packaging, bringing over 4 years of dedicated expertise in market intelligence and strategic analysis across the dynamic world of packaging technologies and solutions.
Learn more about Vidyesh Swar
Reviewed By
Aditi Shivarkar, with 14+ years in packaging market research, specializes in food, beverage, and eco-friendly packaging. She ensures accurate, actionable insights, driving Towards Packaging Analytics & Consulting 's excellence in industry trends and sustainability.
Learn more about Aditi Shivarkar
Download Free Sample
